About BCU CME Meetings Special Editions Meet The Professors Patterns of Care Conference Partnerships Patient Projects Other Tumor Types About us
You are here: Home: BCU 2 | 2009: Edith A Perez, MD: Select Publications

Select Publications

Gianni L et al. Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: Primary efficacy analysis of the NOAH trial. San Antonio Breast Cancer Symposium 2008;Abstract 31.

Joensuu H et al. Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) 5-FU + epirubicin + cyclophosphamide (CEF) adjuvant therapy for high-risk early breast cancer (BC): Interim analysis of the FinXX-trial. San Antonio Breast Cancer Symposium 2008;Abstract 82.

Jones S et al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research trial 9735. J Clin Oncol 2009;27(8):1177-83. Abstract

Miles D et al. Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. Proc ASCO 2008;Abstract LBA1011.

Miller K et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007;357(26):2666-76. Abstract

O’Brien ME et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 2004;15(3):440-9. Abstract

O’Shaughnessy J et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results. J Clin Oncol 2002;20(12):2812-23. Abstract

Sparano J et al. Pegylated liposomal doxorubicin (PLD) plus docetaxel significantly improves time to progression (TTP) compared with docetaxel (D) monotherapy in patients with advanced breast cancer (ABC) treated with adjuvant anthracycline: Results from a randomized phase 3 study. San Antonio Breast Cancer Symposium 2008;Abstract 80.

 

 

 

 

 

 

 

 

 

 

 

Table of Contents Top of Page

BCU Think Tank

CME Test Online

Home · Search

EDITOR
Neil Love, MD

INTERVIEWS

Edith A Perez, MD
- Select publications

Stephen E Jones, MD
- Select publications

Sandra M Swain, MD
- Select publications

Ian E Krop, MD, PhD
- Select publications

 

Breast Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures

Editor's Office

Media Center
PDF
Media Center
Podcast
Previous Editions
Home Terms and Conditions of Use and General Disclaimer | Privacy Policy
Copyright © 2009 Research To Practice. All Rights Reserved